RNA-based therapy has been an expanding area of clinical research since the COVID-19 outbreak. Beyond vaccines, RNA therapies are now being developed to treat a growing number of disease indications. The rapid advancement of RNA drugs has taken various forms, including siRNA, sgRNA, mRNA, circRNA, and saRNA.

In this webinar, we will explore the fundamentals of RNA drug development and the critical role of in vitro transcription (IVT) in manufacturing workflows.

What You’ll Learn:

Basics of RNA drug development and the current landscape.
Overview of GMP manufacturing workflows for RNA therapies.
Key aspects of in-process and release testing panels.

This session is perfect for professionals looking to deepen their understanding of RNA manufacturing processes and ensure their workflows are GMP-compliant.

Presenter: Kenneth Warrington, Ph.D., Executive Director, Strategic Business Development, Head of Technical Services.

RNA Manufacturing 101

Request for services now!!!

Canada

United States

China

Quick Links